Atopic keratoconjunctivitis in children more common than believed

Allergy investigations key to making more accurate diagnosis

Atopic keratoconjunctivitis in children more common than believed
Priscilla Lynch
Priscilla Lynch
Published: Sunday, September 15, 2019
[caption id="attachment_16624" align="alignleft" width="1024"] Frederic Chiambaretta[/caption] ATOPIC keratoconjunctivitis (AKC) in children is more common than believed and requires a multidisciplinary approach for optimal outcomes, yesterday’s dedicated EuCornea session on ocular surface diseases in paediatric patients was told. Frederic Chiambaretta MD, France, acknowledged that distinguishing between vernal keratoconjunctivitis (VKC) and AKC can be challenging. While VKC is mostly associated with adults, it may be more prevalent in children than initially believed, however. He quoted epidemiological data on 134 patients with allergic conjunctivitis, where 55% of patients with AKC reported an onset of symptoms before 10 years of age. In Japanese populations, VKC cases with any history of atopic dermatitis are diagnosed as AKC, regardless of patient age, he added. Allergy investigations are key to helping make a more accurate diagnosis of AKC in children, as is seeing if there is a history of eczema and conjunctivitis/keratitis, he said. Allergists and ophthalmologists need to work together to correctly diagnose these patients as AKC and VKC differ in relation to treatment needs; the dermatologic manifestations (eg, lid eczema) of AKC need specific treatment such as hydration, low-potency skin steroids and skin tacrolimus. Ocular manifestations can also be more severe in AKC, specifically corneal complications, Dr Chiambaretta noted.
Tags: paediatric keratoconjunctivitis
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...